ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)

Sweden · Delayed Price · Currency is SEK

14.90

-0.40 (-2.61%)

Feb 26, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production of Medicine Proteins, & Development of Protein Production Technology	7.83M	8.80M	6.15M	13.73M	15.26M
Production of Medicine Proteins, & Development of Protein Production Technology Growth	-11.07%	43.07%	-55.21%	-10.04%	10.37%
Total	7.83M	8.80M	6.15M	13.73M	15.26M
Total Growth	-11.07%	43.07%	-55.21%	-10.04%	10.37%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
The Nordics	2.00K	1.22M	582.00K	4.01M	799.00K
The Nordics Growth	-99.84%	109.45%	-85.50%	402.25%	-
Other Countries	3.01M	5.83M	4.50M	8.22M	4.46M
Other Countries Growth	-48.36%	29.55%	-45.24%	84.30%	-
Total	3.01M	7.05M	5.08M	12.23M	5.26M
Total Growth	-57.26%	38.70%	-58.45%	132.61%	-61.97%

Source: S&P Global Market Intelligence.